Aspirin And Dipyridamole Capsule, Extended Release
Product Images NDC 16714-964

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aspirin And Dipyridamole (NDC 16714-964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Container (Container)
This is a drug called Aspirin and Extended-Release Dipyridamole that comes in a unit-of-use container that contains 60 capsules. Each capsule contains 25 mg of aspirin and 200 mg of extended-release dipyridamole for treatment. It is recommended to be stored at a temperature between 20°C to 25°C and protected from excessive moisture. Pharmacists are advised to dispense in the unit-of-use container provided by the manufacturer. This drug is manufactured by Dr. Redy's Laboratories Limited in India and distributed by Northstar Rx LLC from Memphis, TN.*
FDA Label Image

Figure (Figure)

Figure (Figure)
The text is a table showing the cumulative stroke rates for different treatment groups over a period of months. The treatment groups include extended-release dipyridamole, aspirin, and placebo. The dosage regimen for all treatment groups is twice a day.*
FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.